These success, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 help the notion of targeting ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Ailments. Scientists feel that blocking this https://courtneya036ssa5.wikifordummies.com/user